We first reported that PEDF inhibits vascular permeability in RAECs via PPARγ under the hypoxic condition and found that PEDF protected cardiomyocytes against ischemia or hypoxia-induced cell apoptosis, both in vivo and in vitro via preventing the activation of caspase-3. This evidence concerns the gene PPARG and ischemia.